- The trend backdrop is active with a 36-week active streak.
- Price is above the Trend Line, keeping the weekly tape constructive.
- Price is above Fair Value, showing premium demand versus the model.
- Activity pressure is positive on the latest completed week.
MARK
JKT
Week ended 07 Aug 2026
Weekly Investor Report
PT Mark Dynamics Indonesia Tbk · Healthcare · Medical Instruments & Supplies
Latest close
1,100 IDR
2.8%
latest week
Weekly setup
Constructive, but selective
The weekly trend is active. Price is 31.9% above the Trend Line and sits at 93.4% of its 52-week range. The latest completed week returned 2.8%, after a 0.9% four-week move. The latest news-sentiment score is 50/100. Near-term considerations: price is close to its 52-week high.
Setup score
72
out of 100
Latest Close
1,100 IDR
7 Aug 2026
1W Return
2.8%
latest completed week
4W Return
0.9%
short-term follow-through
12W Return
35.4%
quarterly tape
Trend Breadth
69.2%
36 of 52 weeks active
Volume Ratio
1.3x
vs 13-week average
- 3 reversal markers appear in the recent smart-money tape.
- Price is close to its 52-week high; watch for continuation or exhaustion.
- Trend Line remains the key weekly regime level.
- Activity pressure is the gauge to monitor for confirmation or fade.
- A volume ratio above 1.5x would show stronger participation in the next move.
Price follow-through
2.8%
Latest completed week; four-week move 0.9%.
Indicator stack
83/78
Trend and activity pressure are weighted against the latest 12-week confirmation window.
Trend backdrop
Active
The trend backdrop defines the current weekly regime.
Patient Capital
Quiet
Activity-pressure buy-signal status for institutional accumulation timing.
News sentiment
50/100
1 relevant articles in the latest sentiment read.
01 · Price action
Study the full chart
Where price is—and whether the trend supports it
The weekly trend is active. Price is 31.9% above the Trend Line and sits at 93.4% of its 52-week range. The latest completed week returned 2.8%, after a 0.9% four-week move.
52-week price path
Price vs Trend Line and Fair Value
Price
Trend Line
Fair Value
02 · Volume and demand
Is real participation confirming the move?
Latest weekly volume is 1.3x the 13-week average. Participation is around or above normal and provides reasonable confirmation.
26-week volume confirmation
Bar height shows volume; colour shows the weekly price direction
13 Feb
20 Feb
27 Feb
6 Mar
13 Mar
20 Mar
27 Mar
3 Apr
10 Apr
17 Apr
24 Apr
1 May
8 May
15 May
22 May
29 May
5 Jun
12 Jun
19 Jun
26 Jun
3 Jul
10 Jul
17 Jul
24 Jul
31 Jul
7 Aug
Up week
Down week
Demand beneath price
Activity pressure and institutional-style signals
These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.
Activity pressure path
Latest 0.9912-week average 0.84
12-week confirmation
Trend active12/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure12/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership12/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.99Current proprietary activity-pressure read.
Buy signals0Accumulation signal count in the latest 12 weeks.
Reversal markers33 reversal markers
No recent accumulation markers. 3 reversal markers.
03 · Momentum and leadership
Is performance persistent—and is the stock leading?
Performance is 0.9% over four weeks, 35.4% over 12 weeks, and 85.6% over one year. The current trend has remained active for 36 consecutive weeks.
Performance by holding period
Active trend streak36 weeks
Active weeks in one year36
Trend breadth69.2%
Activity pressure vs relative leadership
Activity pressureRelative leadership
Pressure1.50Latest activity-pressure read.
Pressure change7.5%Four-week change in activity pressure.
Leadership65.04Latest relative-leadership reading.
RS change-27.2%Four-week change in relative leadership.
04 · Fundamentals and valuation
Open full factor analysis
What investors are paying for—and the quality behind it
A published fundamentals and factor snapshot is not available for this company.
No published fundamental snapshot is available for this company.
05 · Ownership, options, and sentiment
What other market participants are doing
Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.
Insider activity-
No recent insider transactions are stored for this company.
News sentiment50/100
Weighted news tone is neutral across 1 relevant articles.
0 positive · 6 neutral · 0 negativePatient CapitalQuiet
Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.
No recent buy signal
06 · Catalysts and risk
What can move the shares—and how volatile the path has been
Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.
Next earnings-No event is currently stored.
Options expected move-Nearest-chain priced movement where available.
52-week drawdown-3.5%Distance below the 52-week high.
13-week volatility5.6%Standard deviation of weekly returns.
Weekly gains and losses
Latest 26 completed weeksEach bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.
13 Feb
13 Mar
10 Apr
8 May
5 Jun
3 Jul
7 Aug
Weeks higher14 of 2610 weeks finished lower.
Best week+11.5%Week of 31 Jul.
Worst week-9.4%Week of 24 Jul.
Latest week+2.8%Week of 7 Aug.
Shape of recent returns
Strong gains8
Modest gains6
Flat weeks2
Modest losses6
Sharp losses4
Recent vol5.6%13-week weekly-return volatility.
Base vol4.5%52-week weekly-return volatility.
Up/down split25/21Count of positive and negative weeks in the 52-week window.
Average skew4.8% / -2.5%Average positive week versus average negative week.
07 · Sector and peer context
Is this stock leading—or simply moving with its group?
Sector and industry breadth distinguish company-specific strength from a broad group move.
SectorID Healthcare
4-week rank28 / 38
Group average4.5%
Trend breadth15.8%
Trend15.8%active weekly trend signals
MD44.7%positive activity pressure
RS73.7%positive relative leadership
Four-week leaders
IndustryID Medical Instruments & Supplies
4-week rank3 / 4
Group average3.5%
Trend breadth25.0%
Trend25.0%active weekly trend signals
MD50.0%positive activity pressure
RS75.0%positive relative leadership
Four-week leaders
08 · Evidence and weekly data
The underlying research record
Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.
Weekly tape72/100
Trend, activity pressure, participation, and risk combine to a 72/100 tape read.
Indicator analysis85/100Latest 12-week confirmation: trend 12/12, activity pressure 12/12, relative leadership 12/12.
Activity pressure 0.99; 3 reversal markers Factors50/100No published factor snapshot is available yet.
Patient CapitalQuietActivity-pressure buy-signal evidence highlights potential institutional accumulation windows.
No recent buy signal Sentiment50/100Weighted news tone is neutral across 1 relevant articles.
PT Mark Dynamics Indonesia Tbk Reports Earnings Results for the Half Year Ended June 30, 2026 Insiders50/100No recent insider transaction evidence is stored.
Earnings50/100No stored earnings event is currently attached to this ticker.
| Week | Close | Return | Trend Line | Fair Value | Pressure | Leadership | Volume | Trend |
|---|---|---|---|---|---|---|---|---|
| 7 Aug 2026 | 1,100 IDR | 2.8% | 833.7 IDR | 702.2 IDR | 1.50 | 65.04 | 84.2M | On |
| 31 Jul 2026 | 1,070 IDR | 11.5% | 822.6 IDR | 698.2 IDR | 1.59 | 67.89 | 88.6M | On |
| 24 Jul 2026 | 960.0 IDR | -9.4% | 812.6 IDR | 694.7 IDR | 1.51 | 54.33 | 88.7M | On |
| 17 Jul 2026 | 1,060 IDR | -2.8% | 806.2 IDR | 691.9 IDR | 1.55 | 73.54 | 109.6M | On |
| 10 Jul 2026 | 1,090 IDR | 10.1% | 795.8 IDR | 688.2 IDR | 1.39 | 89.40 | 124.3M | On |
| 3 Jul 2026 | 990.0 IDR | 4.2% | 784.5 IDR | 684.3 IDR | 1.16 | 76.99 | 21.7M | On |
| 26 Jun 2026 | 950.0 IDR | 2.7% | 777.4 IDR | 681.0 IDR | 0.88 | 72.15 | 23.5M | On |
| 19 Jun 2026 | 925.0 IDR | 8.8% | 772.2 IDR | 677.9 IDR | 0.71 | 62.51 | 23.1M | On |
| 12 Jun 2026 | 850.0 IDR | 7.6% | 764.6 IDR | 674.9 IDR | 0.67 | 55.51 | 39.9M | On |
| 5 Jun 2026 | 790.0 IDR | -0.6% | 758.1 IDR | 672.3 IDR | 0.60 | 56.90 | 19.8M | On |
| 29 May 2026 | 795.0 IDR | -1.9% | 752.9 IDR | 670.3 IDR | 0.70 | 45.82 | 54.5M | On |
| 22 May 2026 | 810.0 IDR | -0.3% | 748.0 IDR | 668.1 IDR | 0.52 | 48.80 | 91.5M | On |
| 15 May 2026 | 812.6 IDR | 3.0% | 740.7 IDR | 665.9 IDR | 0.12 | 37.88 | 61.2M | On |
| 8 May 2026 | 789.1 IDR | 3.1% | 732.9 IDR | 663.7 IDR | -0.17 | 29.83 | 79.8M | On |
How to use this report
This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.